DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 206799
The generic ingredient in VORICONAZOLE is voriconazole. There are fourteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the voriconazole profile page.
Summary for 206799
Tradename: | VORICONAZOLE |
Applicant: | Novel Labs Inc |
Ingredient: | voriconazole |
Patents: | 0 |
Therapeutic Class: | Antifungals |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 206799
Ingredient-type | Azoles |
Mechanism of Action | Cytochrome P450 3A4 Inhibitors Cytochrome P450 2C19 Inhibitors Cytochrome P450 2C9 Inhibitors |
Medical Subject Heading (MeSH) Categories for 206799
Suppliers and Packaging for NDA: 206799
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VORICONAZOLE | voriconazole | FOR SUSPENSION;ORAL | 206799 | ANDA | Novel Laboratories, Inc. | 40032-038 | N | 40032-038-60 |
VORICONAZOLE | voriconazole | FOR SUSPENSION;ORAL | 206799 | ANDA | Lupin Pharmaceuticals,Inc. | 43386-038 | N | 43386-038-60 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 200MG/5ML | ||||
Approval Date: | May 31, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription